DE2705797A1 - 13-azaprostaglandine - Google Patents

13-azaprostaglandine

Info

Publication number
DE2705797A1
DE2705797A1 DE19772705797 DE2705797A DE2705797A1 DE 2705797 A1 DE2705797 A1 DE 2705797A1 DE 19772705797 DE19772705797 DE 19772705797 DE 2705797 A DE2705797 A DE 2705797A DE 2705797 A1 DE2705797 A1 DE 2705797A1
Authority
DE
Germany
Prior art keywords
group
hydrogen
denotes
choh
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19772705797
Other languages
German (de)
English (en)
Inventor
Duccio Favara
Umberto Guzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE2705797A1 publication Critical patent/DE2705797A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19772705797 1976-02-23 1977-02-11 13-azaprostaglandine Ceased DE2705797A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7043/76A GB1553293A (en) 1976-02-23 1976-02-23 Azaprostaglandins

Publications (1)

Publication Number Publication Date
DE2705797A1 true DE2705797A1 (de) 1977-09-01

Family

ID=9825554

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772705797 Ceased DE2705797A1 (de) 1976-02-23 1977-02-11 13-azaprostaglandine

Country Status (6)

Country Link
US (1) US4182903A (enExample)
JP (1) JPS52102253A (enExample)
CA (1) CA1100955A (enExample)
DE (1) DE2705797A1 (enExample)
FR (1) FR2366276A1 (enExample)
GB (1) GB1553293A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327092A (en) 1980-04-30 1982-04-27 Glaxo Group Limited Aminocyclopentane alkenoic acids and esters and pharmaceutical formulations

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA793452B (en) * 1978-07-11 1980-06-25 Glaxo Group Ltd Prostanoid compounds
US4438111A (en) 1980-01-09 1984-03-20 Glaxo Group Limited Prostanoid compounds and pharmaceutical formulations
ZA81114B (en) 1980-01-09 1982-01-27 Glaxo Group Ltd Prostanoid compounds and their preparation and pharmaceutical formalation
US4371530A (en) * 1980-07-04 1983-02-01 Glaxo Group Limited Aminocyclopentanone amides and pharmaceutical formulation
EP0044711B1 (en) * 1980-07-22 1984-03-14 Ono Pharmaceutical Co., Ltd. 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof
CA1191134A (en) * 1981-04-29 1985-07-30 Eric W. Collington Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
IL67041A (en) * 1981-10-29 1988-03-31 Glaxo Group Ltd 2-aminocyclopentane alkanoic and alkenoic acid esters,process for their preparation and pharmaceutical compositions containing them
DE3610952A1 (de) * 1986-04-02 1987-10-08 Hagen Batterie Ag Verfahren zum herstellen von akkumulatoren mit akkumulatorplattensaetzen und nach diesem verfahren hergestellter akkumulator
JPS63207058A (ja) * 1987-02-24 1988-08-26 Shin Kobe Electric Mach Co Ltd 密閉形蓄電池の製造法
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327092A (en) 1980-04-30 1982-04-27 Glaxo Group Limited Aminocyclopentane alkenoic acids and esters and pharmaceutical formulations

Also Published As

Publication number Publication date
GB1553293A (en) 1979-09-26
FR2366276A1 (fr) 1978-04-28
US4182903A (en) 1980-01-08
CA1100955A (en) 1981-05-12
FR2366276B1 (enExample) 1981-11-27
JPS52102253A (en) 1977-08-27
JPS6113469B2 (enExample) 1986-04-14

Similar Documents

Publication Publication Date Title
DE2437388A1 (de) Prostansaeurederivate
DE2313868A1 (de) 11-deoxyprostaglandinderivate und deren herstellungsverfahren
DE2242239A1 (de) Neue 2-descarboxy-2- eckige klammer auf tetrazol-5-yl eckige klammer zu prostaglandine, verfahren zu ihrer herstellung sowie zwischenprodukte
DE2355540C2 (de) 16-Phenoxy-ω-tetranorprostaglandinderivate
DE2705797A1 (de) 13-azaprostaglandine
DE2831761C2 (de) 2,3- und 2,3,6-substituierte-4-Pyrone und deren Verwendung
AT395421B (de) Verfahren zur herstellung von neuen cyclopenthylethern
DD210027B3 (de) Verfahren zur herstellung von carbacyclinderivaten
CH638773A5 (en) Prostane derivatives and process for their preparation
CH635072A5 (de) Prostaglandin-analoge.
DE2322142C2 (de) Prostansäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische oder veterinäre Zuammensetzungen
DE2536382A1 (de) Pyrrolidin-derivate
DE2330333C2 (de) 9-Desoxy-prosta-5,9(10),13-triensäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Zubereitungen
DE2539116C2 (de) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandine, Verfahren zu ihrer Herstellung sowie sie enthaltende pharmazeutische Mittel
US4189606A (en) 13-Azaprostaglandins
DE2705613C3 (de) Bicycloheptylderivate von Prostagiandinen und Verfahren zu deren Herstellung sowie Zwischenprodukte zu deren Herstellung und Arzneimittel, welche die Bicycloheptylderivate enthalten
DE3430626A1 (de) 16-fluor-16,17-didehydroprostanoide, verfahren zu deren herstellung und pharmazeutische praeparate
DE2417996A1 (de) Alkylderivate von prostansaeuren und deren herstellung
DE2647969A1 (de) Cyclische amide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2945781A1 (de) Prostacyclinzwischenprodukte und protacyclinanaloge
DE2739277A1 (de) 11-deoxy-11-oxaprostaglandinverbindungen
DE2611788A1 (de) Fluorprostaglandine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2618341A1 (de) Neue dl-8-aza-9-keto-15-hydroxy- prostan- und -prost-13-trans-ensaeuren, deren 15-methylderivate und pharmazeutisch zulaessige, nicht toxische niederalkylester und salze der carbonsaeurefunktion sowie verfahren zur herstellung solcher verbindungen
CH640847A5 (en) Process for preparing analogues of 5,6-dihydroprostacyclin
DE2814711A1 (de) Neue prostaglandin-analoge

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection